Cadmium-induced endothelial dysfunction mediated by asymmetric dimethylarginine. by Al-Naemi, Hamda A & Das, Sandra Concepcion
RESEARCH ARTICLE
Cadmium-induced endothelial dysfunction mediated
by asymmetric dimethylarginine
Hamda A. Al-Naemi1,2 & Sandra Concepcion Das1,2
Received: 8 September 2019 /Accepted: 14 February 2020
# The Author(s) 2020
Abstract
Cadmium (Cd) is a naturally occurring toxic heavy metal with no known essential biological functions. Exposure to Cd increases
the risk of cardiovascular disease by disrupting vascular homeostasis at the endothelium. The aim of the study was to evaluate the
effect of chronic low-dose Cd on vascular structure and function. Fifty adult male Sprague Dawley rats were grouped and
assigned to one of two treatments for 14 weeks. The control group received normal water for 14 weeks while the Cd-treated
group received 15 mg Cd/kg B.W. as CdCl2 in water for 10 weeks. A subset of the Cd-treated group received 15 mg Cd/kg B.W.
as CdCl2 in water for 10 weeks followed by 4 weeks of normal water. Results show an overall decline in vascular function and
structure. Withdrawal of Cd treatment showed a considerable restoration of vascular structure and vasorelaxation function.
Additionally, asymmetric dimethylarginine (ADMA) bioavailability was found to be lowered over time. Interestingly, the
expression of eNOS in the Cd-treated group was found to be significantly elevated during the exposure by more than 3-fold
in comparison with that in the control group. This protein expression was similar to the control group after the withdrawal of Cd
treatment. Taken together, the results suggest that ADMA, an eNOS inhibitor, may play a role in altering endothelial function in
the presence of cadmium. In conclusion, the findings indicate that even at low doses, Cd leads to endothelial dysfunction
mediated by ADMA.
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Introduction
Cadmium is a widely distributed environmental and industrial
pollutant that has a negative impact on human health follow-
ing long- and short-term exposure. Cadmium is released into
the environment via anthropogenic activities like metal
smelting, mining, fuel combustion, and use of phosphate fer-
tilizers (Cullen and Maldonado 2013). Furthermore, it has
been well established that cadmium is one of the considerable
toxicants in tobacco smoke (Satarug and Moore 2004;
Milnerowicz et al. 2015).
Human exposure to cadmium primarily occurs via inges-
tion of contaminated food and water, or inhalation. Studies
have shown that cadmium causes organ damage by accumu-
lation in various organs such as the liver, kidneys, lungs, testis,
heart, bone, eye, and brain (Thévenod and Lee 2013). Current
research in human and animal models shows that the vascular
wall is also a target of cadmium deposition disrupting vascular
homeostasis (Abu-Hayyeh et al. 2001; Prozialeck et al. 2008).
Human population studies show inconsistent results. Chronic
cadmium exposure in human subjects has been shown to in-
duce endothelial impairment due to decreased nitric oxide
bioavailability and increased asymmetric dimethylarginine
(ADMA) (Lukkhananan et al. 2015). Furthermore, human
exposure to cadmium has been associated with hypertension
and high cadmium body burden (Franceschini et al. 2017;
Garner and Levallois 2017; An et al. 2017). However, studies
have also shown that there is no relationship between high
blood pressure and cadmium body burden, with results
Responsible editor: Mohamed Abdel-Daim
* Hamda A. Al-Naemi
halnaemi@qu.edu.qa
1 Laboratory Animal Research Center, Qatar University,
P.O. Box 2713, Doha, Qatar
2 Department of Biological and Environmental Sciences, College of
Arts & Sciences, Qatar University, Doha, Qatar
https://doi.org/10.1007/s11356-020-08116-5
/Published online: 2 March 2020
Environmental Science and Pollution Research (2020) 27:16246–16253
varying by type of biomonitoring sample, sex, and smoking
status (Tellez-Plaza et al. 2008; Agarwal et al. 2011; Lee et al.
2016).
In vivo exposure to cadmium in drinking water resulted in
the attenuation of endothelial nitric oxide synthase (eNOS)
protein expression in aorta of Sprague Dawley rats (Yoopan
et al. 2008). It has been previously demonstrated that ingestion
of 15 ppm of cadmium salt in drinking water intoxicated rats
and showed serum cadmium concentrations up to the World
Health Organization toxic limit (Larregle et al. 2008;
Calderoni et al. 2010). Subchronic exposure to cadmium-
contaminated water for 3 months resulted in an increase of
systolic blood pressure and reduced acetylcholine-induced
vascular response (Yoopan et al. 2006). Proposed mechanism
of these changes includes the disruption of calcium channels
and nitric oxide bioavailability by induction of oxidative stress
inhibiting eNOS (Martynowicz et al. 2004; Cannino et al.
2009).
Even though the aorta is affected by cadmium at low con-
centrations below reference values, the mechanisms by which
vascular homeostasis is disrupted is not clearly understood.
There is a lack of reports showing the vascular effects of
cadmium at a chronic low dose. In this study, we aim to eval-
uate the effect of vascular wall damage under a chronic dose
of cadmium via ingestion to evaluate (1) the structural alter-
ations in the aorta, (2) the vasoreactivities, and (3) its relation
to ADMA bioavailability, to explain some of the mechanisms
behind the cadmium-induced endothelial dysfunction.
Materials and methods
Study design and experimental procedures
Fifty adult (8-week-old) male Sprague Dawley (SD) rats were
obtained from the Laboratory Animal Research Center
(LARC), Qatar University, were housed in individually venti-
lated cages (IVC), and were maintained in standard conditions
of room temperature (18–22 °C), relative humidity (40–60%),
and on a 12-h light:12-h dark cycle. The rats were randomly
assigned to one of two groups for 14 weeks: control group or
Cd treatment (Cd-treated). The control group received drink-
ing water for 14 weeks. The Cd-treated group received 15 mg
Cd/kg B.W. as CdCl2 (BDH Chemicals, England) in water for
10 weeks followed by 4 weeks of drinking water. The animals
were provided ad libitum access to standard rodent chow and
drinking water during the experiment. Animals were
sacrificed 10 weeks after cadmium treatment and at 4 weeks
as recovery period after cessation of cadmium treatment under
anesthesia with sodium thiopentone (40 mg/kg B.W., i.p.;
Ilium, Australia), and fasting blood was collected from the
retro-orbital sinus. Following blood collection, animals were
euthanized. The thoracic aorta was dissected and divided into
three parts: the first part was for vasoreactivity examination;
the second part was fixed in 10% buffered formalin for histol-
ogy analysis; and the third part was frozen in liquid nitrogen
and preserved in − 80 °C for protein analysis.
All experimental procedures were approved by the
Institutional Animal Care and Use Committee of Qatar
University (Approval No. QU-IACUC 038/2017).
Blood pressure measurement
Blood pressure was measured at different time points during
the study at weeks 0, 5, 10, and 14. Animals were placed in a
pre-warmed cage for 5 min and restrained during the record-
ing protocol. Blood pressure was recorded by the non-
invasive tail cuff method (CODA, Kent Scientific
Corporation) for 10 cycles with 5 acclimatization cycles as
previously described (Wang et al. 2017). The average of ac-
cepted cycles was calculated and analyzed.
Vascular contractility analysis
Vascular contractility was studied by modifying a protocol
described previously (Owu et al. 2013). Briefly, the isolated
thoracic aorta was cleaned of connective tissues and segment-
ed to approximately 1 mm in length. Free of connective tissue,
the rings were mounted in a tissue chamber containing phys-
iological salt solution with a composition (in mM) of the fol-
lowing: 112 NaCl, 5 KCl, 25 NaHCO3, 1.8 CaCl2, 0.5
KH2PO4, 1 MgCl2, 0.5 NaH2PO4, 10 glucose, gassed with
95% O2 and 5% CO2, maintained at a resting tension of
1.2 g at 37 °C. One end of the aorta was fixed while the other
was mounted to a force transducer for isometric tension. The
tension was measured by digital force output software
(750TOBS, DMT). The rings were equilibrated for 15 min
at 1.2 g. To analyze the effect of Cd treatment on contractile
response, concentration–effect curves (10−7 to 10−2 M) were
obtained for the agonist noradrenaline (NA) and for the vaso-
dilator acetylcholine (Ach). Vasoconstriction response to NA
is expressed as grams of tension. Vasodilator concentration–
effect curves were obtained for rings pre-contracted at approx-
imately 80% of maximal contraction. Relaxation induced by
ACh was expressed as a percentage of NA-induced
contraction.
ADMA bioavailability analysis
ADMA levels in plasma were determined by using the ELISA
method (DLD Diagnostika, Germany) as per the user manual
described previously (Schulze et al. 2004). Aliquoted plasma
was thawed and pre-treated to be acylated in a reaction plate.
The acylated ADMA was detected using rabbit anti-N-acyl-
ADMA antiserum with the enzyme conjugate anti-rabbit-
immunoglobulin G peroxidase. The color reaction was
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stopped using a stopping solution and the optical density was
read at 450 nm using a microtiter plate.
Histological analysis
Dissected thoracic aortas were fixed in 10% buffered formalin
for 24 h. The fixed tissues were dehydrated in alcohol series,
infiltrated with xylene, and embedded in paraffin. The embed-
ded tissues were sectioned at 5 μm and stained in hematoxylin
and eosin (Xu et al. 2015). The stained sections were evaluat-
ed for general histopathological changes. Imaging was done
using a microscope (Zeiss Primo Star) fitted with a camera
(Canon Powershot A650).
Protein expression analysis
Liquid nitrogen–frozen sections were mechanically pulver-
ized, homogenized, and incubated for 30 min in cell lysis
buffer (Thermo Scientific, USA) containing protease inhibitor
cocktail (Thermo Scientific, USA). The homogenized sam-
ples were centrifuged at 10,000 rpm for 10 min at 4 °C. The
supernatants were collected and quantified for protein concen-
trations by Bradford reagent (Bio-Rad, USA).
Immunoblotting protocol was adopted from a previously
published study (Zhang et al. 2018) with modifications.
Briefly, the protein samples (40 μg) were loaded and subject-
ed to 6–10% SDS-polyacrylamide gels and blotted to
polyvinylidene difluoride (PVDF) membranes (GE
Healthcare Limited, Buckinghamshire). The membranes were
washed with TBST (20 mM Tris-buffered saline and 0.1%
Tween-20) for 5 min and incubated in a blocking buffer (3%
skimmed dry milk in TBST) for 1 h with agitation. The mem-
brane was then washed in TBST and incubated with specific
primary antibody (Abcam), eNOS (ab76198, 1:750) and α-
actin (ab5694, 1:100) at 4 °C overnight. The blots were
washed and incubated with HRP-conjugated secondary anti-
body (Abcam, ab205719, 1:5000; ab6721, 1:2000).
Immunoreactive bands were visualized using enhanced
chemiluminescence (Thermo Scientific, USA).
For densitometric analysis, an image analysis system
(Image Studio Lite Ver 5.2) was used to quantify the band
intensities of eNOS and α-actin. The results were normalized
to the expression ofα-actin in each group and represented as a
fold change.
Statistical analysis
Data were expressed as mean ± S.E.M. Two-way analysis of
variance (ANOVA) was used to determine statistical signifi-
cance (GraphPad Prism 8.0). P < 0.05 was considered statisti-
cally significant.
Results
Effect of cadmium exposure on vasocontractility
Vasoresponse to noradrenaline and acetylcholine was mea-
sured to assess the effect of cadmium exposure on contractil-
ity. No significant difference in the vasocontractility of the
aorta at week 10 (Fig. 1a). Cadmium exposure followed by
withdrawal increased the maximal contraction induced by
noradrenaline (Fig. 1c). However, this increase was not statis-
tically significant. The vasoresponse to acetylcholine is altered
at week 10 (Fig. 1b). The Cd-treated group shows a statisti-
cally significant response beginning from 10−7 until 10−4 M.
In Fig. 1d, the vasorelaxation response was unaffected.
Effect of cadmium exposure on blood pressure
Mean arterial pressure was monitored at different time points
and recorded. The results obtained show a steep decline in mean
arterial pressure for 5 weeks followed by a steady increase until
week 14 in the Cd-treated group (as shown in Fig. 2). This shift
was not statistically significant against the control group.
Effect of cadmium exposure on ADMA bioavailability
Evaluation of the inhibitor ADMA bioavailability showed the
highest bioavailable concentration at week 5 and gradually
decreased until week 14 (Fig. 3). The difference of bioavail-
able concentrations from week 5 to week 10 and week 14 was
found to be statistically significant (P < 0.05). When com-
pared with the respective control group, ADMA increased
by 80%, 21%, and 8% at week 5, week 10, and week 14,
respectively. Overall, ADMA bioavailability increased by
35% compared with the control group.
Effect of cadmium exposure on histological structure
To assess aortic integrity, hematoxylin–eosin-stained aortic sec-
tions were evaluated for alterations (Fig. 4). The control group
showed a normal histological structure starting with a smooth,
continuous endothelial cell (EC) layer in the tunica intima (TI)
followed by a smooth muscle cell (SMC) layer in the tunica
media (TM). The elastic fibers were arranged into continuous
lamellae. At week 10, the Cd-treated group shows a rough EC
layer with areas of denudation or disruption of continuity in the
TI. Focal blood cell adhesions and subintimal thickening were
also seen. There was an observed irregularity in the SMC ar-
rangement of the TM accompanied with diffuse thickening.
Irregularities were detected in the elastic laminae of the aorta
wall (Fig. 4b). At week 14, the Cd-treated group showed a
smooth, flat, and continuous arrangement of the endothelial
cells in the TI accompanied with a regular smooth spindle-
shaped arrangement of the SMC in the TM layer (Fig. 4c).
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Effect of cadmium exposure on eNOS expression
Densitometric evaluation of the expression of eNOS shows an
elevation in the expression of eNOS in the Cd-treated group
(Fig. 5). In week 5, a 2.5-fold increase in eNOS expression
was observed in the Cd-treated group compared with the con-
trol group. More than a 3-fold increase was observed for the
Cd-treated group in week 10 compared with the control group.
Fig. 1 The effects of cadmium exposure on vasocontractility response of
thoracic aorta of adult male SD rats to noradrenaline and acetylcholine. a
Noradrenaline dose–response curve at week 10. b Acetylcholine dose–
response curve at week 10. cNoradrenaline dose–response curve at week
14. d Acetylcholine dose–response curve at week 14. Data expressed as
mean ± S.E.M. *P < 0.05, **P < 0.01
Fig. 3 The effects of chronic cadmium exposure on bioavailability of
ADMA in blood plasma of adult male SD rats. Data expressed as mean
± S.E.M. Columns sharing the same alphabet are statistically significant.
a: P < 0.05, b: P < 0.05
Fig. 2 The effects of chronic cadmium exposure on blood pressure in
adult male SD rats. Changes in mean arterial pressure over 14 weeks.
Data expressed as mean ± S.E.M.
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However at week 14, the eNOS expression in the Cd-treated
group was similar with that in the control group. At week 14,
the expression of eNOS was not statistically significant in
comparison with that in the control group.
Discussion
Epidemiological studies evaluating the association between
prevalence of hypertension and Cd exposure have reported
inconsistent results. Some studies have reported a positive
association between Cd exposure and hypertension in the pop-
ulation (Tellez-Plaza et al. 2008; Garner and Levallois 2017;
Wang and Wei 2018). These outcomes are contrary to those
reported to show a negative correlation between Cd exposure
and elevated blood pressure (Staessen et al. 1984, 1991, 2000;
Nawrot et al. 2008; Garner and Levallois 2017). Animal stud-
ies have shown the effect of Cd exposure to elevation of blood
pressure, particularly systolic pressure (Kacar Kocak et al.
2009). However, hypertension is associated with alteration
in vascular structure and function. In the present study, the
effects of chronic Cd exposure on vascular structure and func-
tion were studied. Adult male SD rats were exposed to daily
Cd dose of 15 ppm for 10 weeks followed by withdrawal for
4 weeks.
The histological examination of the structural integrity of
the aorta shows numerous changes to the endothelial and me-
dial layer which is indicative of altered function. During Cd
exposure, an array of structural changes was observed includ-
ing abnormal and disorganized endothelium, fragmented elas-
tic lamellae, degeneration of SMCs, formation of vacuoles,
and thickening of the medial layer. During the recovery peri-
od, the vascular structure seems to have restored to normal
arrangement. Increasing reports have reviewed the importance
of the integrity of endothelial structure for viable vascular
function (Kolluru et al. 2006; Messner et al. 2009; Knoflach
et al. 2011; Oliveira et al. 2011). Additionally, there is a grow-
ing volume of evidence implicating the endothelium as a pri-
mary target of Cd toxicity (Prozialeck et al. 2008; Nagarajan
et al. 2013). The components of the medial layer of the
aorta—the smooth muscle cell (SMC) and connective tissue
like elastin and collagen—contribute to the elasticity of the
aorta (Shirwany and Zou 2010). Our findings are in accor-
dance with those observed by Pérez Díaz et al. (2013)
reporting irregular arrangement of luminal layers and cyto-
plasmic alterations of the endothelial cell layer in aortas of
adult male Wistar rats treated with 15 ppm Cd for 2 months.
In vitro experiments on endothelial cells have shown that Cd










Fig. 4 The effects of chronic cadmium exposure on aortic integrity of
adult male SD rats. L indicates the luminal side showing aortic
histological structure of the a control group with black arrows
indicating a smooth, flat, and continuous endothelial layer of the TI and
regular SMC arrangement in the TM; b Cd-treated group at week 10 with
black arrow heads indicating denuded, discontinuous endothelium with
irregular SMC in TM. Red arrow indicates formation of vacuoles, blue
arrow indicates the hyperplasia of the SMC, and red arrow head indicates
degeneration of the SMC; and c Cd-treated group at week 14 with black
arrow indicating a continuous endothelial layer of the TI and regular
organization of the SMC in the TM. (H & E, × 400)
Fig. 5 Effect of chronic cadmium exposure on eNOS expression. Fold
change in eNOS expression in the aorta are represented above after
correcting against α-actin. Data expressed as mean ± S.E.M, n = 4.
*P < 0.05
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toxic level, lead to increased cell permeability due to cell death
(Messner et al. 2009; Pérez Díaz et al. 2013). Sangartit et al.
(2014) reported the thickening and stiffening of the aortic wall
in Cd-exposed mice which were associated with alterations in
the vascular composition. Similar outcomes are also reflected
in the current study suggesting altered mechanical forces dur-
ing exposure to Cd that may be triggered by adaptive
restructuring of the aorta.
Besides structural changes, functional changes may super-
impose to perturb vascular health, thereby altering the func-
tion of the aorta. This study has shown an overall depression
in mean arterial pressure. The abrupt fall in mean arterial pres-
sure between baseline (week 0) and week 5 may be attributed
to the lack of conditioning of the animals to the blood pressure
protocol. A review by Nomiyama and Nomiyama (2000) sug-
gests that changes in blood pressure are dependent on the Cd
dose such that prolonged exposure of a low dose may elevate
blood pressure marginally whereas a higher Cd dose may
depress blood pressure, only in hypertensive individuals.
This suggests that Cd exposure tends to alter blood pressure
in hypertensive animals. There is evidence to suggest that
heart rate is unaltered by Cd exposure. A study by Ozturk
et al. (2009) claimed that chronic Cd exposure at 15 ppm for
60 days has no effect on the heart rate of 3-month-old male
Wistar albino rats. The current study used similar daily dose
(15 ppm of CdCl2) for 10 weeks and showed no statistically
significant alteration in the heart rate. Despite differences in
the period of exposure, age, and strain of the animals used in
the study, our findings are in agreement with the prior cited
references.
An analysis of the effects of Cd exposure on contractile
vasoresponse shows a statistically significant leftward shift
in the Ach-induced relaxation after 10 weeks and a slight
restoration of vasorelaxation response after withdrawal of
Cd treatment. However, this restoration of vasorelaxation re-
sponse was not statistically significant. Earlier studies report-
ed a decrease in the Ach-induced vasorelaxation (Göçmen
et al. 2000; Gökalp et al. 2009). Yoopan et al. (2008) predicted
that Cd may interact with the thiol groups of muscarinic re-
ceptors altering the ligand binding site consequently decreas-
ing the muscarinic receptor responses to Ach. Alternatively,
Gökalp et al. (2009) observed a reduction in the endothelium-
dependent relaxation attributed to Cd-induced inhibition of
nitric oxide (NO) formation.
One of the factors implicated in the prognosis of cardiovas-
cular disease is the bioavailability of NO in circulation. To
elucidate whether the attenuation in Ach-induced vasorelax-
ation is mediated by the eNOS endogenous inhibitor—
asymmetric dimethyl arginine (ADMA)—bioavailability
was studied. The results of this study show a significant in-
crease in ADMA after 5 weeks of Cd exposure that decreases
over time until after withdrawal. This study supports evidence
from clinical observations that subjects with prolonged heavy
metal exposure exhibit endothelial dysfunction mediated by
increased ADMA in circulation (Lukkhananan et al. 2015;
Ochoa-Martínez et al. 2018).
A strong relationship between bioavailability of ADMA
and NO has been reported in literature (Sibal et al. 2010;
Osorio-Yáñez et al. 2017; Chen et al. 2018; Liu et al. 2018).
One of the factors influencing the bioavailability of NO is
eNOS expression. Results of eNOS expression show an upreg-
ulation in the expression. A study by Takahashi et al. (2004)
reported a significant upregulation in the expression of eNOS
along with a slight increase in Ach-induced relaxation in acute-
ly Cd-treated aortic strips. The findings of our study are con-
sistent with that of Takahashi et al., suggesting that the increase
in Ach-induced relaxation through eNOS activation mediated
by NO is associated with the elevated expression of eNOS in
the Cd-treated group at week 10. This further corroborates the
decrease in the Ach-induced relaxation in the aorta of Cd-
treated rats at week 14 that follows the pattern of expression
of eNOS. Takahashi et al. (2004) explained that the augmented
eNOS expression by Cd administration, which may lead to
increased suppression of vasoconstriction, could also augment
contraction by α-adrenoreceptor activation.
Cadmium is known to induce oxidative stress by either
overwhelmed production of reactive oxygen species (ROS) or
weakening antioxidant defense mechanisms, or a combination
of both (Cuypers et al. 2010). The eNOS expression in vitro in
human coronary artery endothelial cells (HCAECs) grown in
culture and in vivo in intact animals was upregulated by an
increase in ROS activity (Zhen et al. 2008). This effect appears
to be partially mediated by limiting the bioavailability of NO,
thereby exerting a negative feedback on the expression of
eNOS by activating a transcription factor, nuclear factor-
kappa B (Zhen et al. 2008). This suggests that further experi-
ments looking at the role of nuclear factor-kappa B on the
internal inhibition of eNOS expression could help to understand
the impact of Cd toxicity on the vascular system.
In overview, chronic Cd exposure alters vascular structure
inciting adaptive mechanisms represented by altered vascular
function. Interestingly, a 4-week recovery from the Cd treat-
ment seems to improve vascular structure and function. The
findings of this study further support the hypothesis that even
at low doses, not only is the endothelium a primary target of
Cd toxicity but the vascular SMC as well. Further studies
aimed at the role of endogenous inhibitors (like ADMA) are
needed to understand the pathway by which Cd mediates vas-
cular function and structure.
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